pubmed.ncbi.nlm.nih.gov

Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder - PubMed

  • ️Wed Oct 01 2025

. 2024 Sep 18;391(1):104-118.

doi: 10.1124/jpet.124.002272.

Affiliations

Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder

Ashley N Ewens et al. J Pharmacol Exp Ther. 2024.

Abstract

Human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) affects nearly half of the 39 million people living with HIV. HAND symptoms range from subclinical cognitive impairment to dementia; the mechanisms that underlie HAND remain unclear and there is no treatment. The HIV protein transactivator of transcription (TAT) is thought to contribute to HAND because it persists in the central nervous system and elicits neurotoxicity in animal models. Network hyperexcitability is associated with accelerated cognitive decline in neurodegenerative disorders. Here we show that the antiepileptic drug levetiracetam (LEV) attenuated aberrant excitatory synaptic transmission, protected synaptic plasticity, reduced seizure susceptibility, and preserved cognition in inducible TAT (iTAT) transgenic male mice. iTAT mice had an increased frequency of spontaneous excitatory postsynaptic currents in hippocampal slice recordings and impaired long-term potentiation, a form of synaptic plasticity that underlies learning and memory. Two-week administration of LEV by osmotic minipump prevented both impairments. Kainic acid administered to iTAT mice induced a higher maximum behavioral seizure score, longer seizure duration, and shorter latency to first seizure, consistent with a lower seizure threshold. LEV treatment prevented these in vivo signs of hyperexcitability. Lastly, in the Barnes maze, iTAT mice required more time to reach the goal, committed more errors, and received lower cognitive scores relative to iTAT mice treated with LEV. Thus, TAT expression drives functional deficits, suggesting a causative role in HAND. As LEV not only prevented aberrant synaptic activity in iTAT mice but also prevented cognitive dysfunction, it may provide a promising pharmacological approach to the treatment of HAND. SIGNIFICANCE STATEMENT: Approximately half of people living with human immunodeficiency virus (HIV) also suffer from HIV-associated neurocognitive disorder (HAND), for which there is no treatment. The HIV protein transactivator of transcription (TAT) causes toxicity that is thought to contribute to HAND. Here, the antiepileptic drug levetiracetam (LEV) prevented synaptic and cognitive impairments in a TAT-expressing mouse. LEV is widely used to treat seizures and is well-tolerated in humans, including those with HIV. This study supports further investigation of LEV-mediated neuroprotection in HAND.

Copyright © 2024 by The American Society for Pharmacology and Experimental Therapeutics.

PubMed Disclaimer

Similar articles

References

    1. Abrahamsson TChou CYCLi SYMancino ACosta RPBrock JANuro EBuchanan KAElgar DBlackman AV, et al. (2017) Differential regulation of evoked and spontaneous release by presynaptic NMDA receptors. Neuron 96:839–855.e5. - PubMed
    1. Alford K, Daley S, Banerjee S, Hamlyn E, Trotman D, Vera JH (2022) “A fog that impacts everything”: a qualitative study of health-related quality of life in people living with HIV who have cognitive impairment. Qual Life Res 31:3019–3030. - PMC - PubMed
    1. Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13:93–110. - PMC - PubMed
    1. Baek EJ, Kim H, Basova LA, Rosander A, Kesby JP, Semenova S, Marcondes MCG (2020) Sex differences and Tat expression affect dopaminergic receptor expression and response to antioxidant treatment in methamphetamine-sensitized HIV Tat transgenic mice. Neuropharmacol 178:108245. - PMC - PubMed
    1. Baez A, Van Brunt T, Moody G, Wollmuth LP, Hsieh H (2020) Voltage dependent allosteric modulation of IPSCs by benzodiazepines. Brain Res 1736:146699. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources